Friday, December 5, 2008 - 4:01AM EST

Review Articles

11. Current treatment paradigms for locally advanced non-small cell lung cancer.

Author
Rigas JR; Kelly K;
Institution
Dartmouth Medical School, Lebanon, NH 03756, USA. james.r.rigas@dartmouth.edu
Journal
J Thorac Oncol. 2007 Jun;2 Suppl 2:S77-85.
Abstract URL
Click here to view abstract

12. Amrubicin for non-small-cell lung cancer and small-cell lung cancer.

Author
Kurata T; Okamoto I; Tamura K; Fukuoka M; Kurata T; Okamoto I; Tamura K; Fukuoka M;
Institution
Department of Medical Oncology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan. ctc002@poh.osaka-med.ac.jp
Journal
Invest New Drugs. 2007 Oct;25(5):499-504. Epub 2007 Jul 13.
Abstract URL
Click here to view abstract

13. Chemotherapy and surgery versus surgery alone in non-small cell lung cancer.

Author
Burdett SS; Stewart LA; Rydzewska L;
Institution
MRC Clinical Trials Unit, Meta-Analysis Group, 222 Euston Road, London, UK, NW1 2DA. sb@ctu.mrc.ac.uk
Journal
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006157.
Abstract URL
Click here to view abstract

14. Erlotinib: recent clinical results and ongoing studies in non small cell lung cancer.

Author
Perez-Soler R;
Institution
Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467-2490, USA. rperezso@montefiore.org
Journal
Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4589-92.
Abstract URL
Click here to view abstract

15. Bevacizumab in non small cell lung cancer.

Author
Sandler A;
Institution
Thoracic Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232-6307, USA. alan.sandler@vanderbilt.edu
Journal
Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4613-6.
Abstract URL
Click here to view abstract

16. Developments in the treatment of non-small cell lung cancer.

Author
Gkiozos I; Charpidou A; Syrigos K;
Institution
Athens University School of Medicine, Head, Oncology Unit, Third Department of Medicine Athens School of Medicine, Building Z, Sotiria General Hospital, Mesogion 152, 115 27 Athens, Greece.
Journal
Anticancer Res. 2007 Jul-Aug;27(4C):2823-7.
Abstract URL
Click here to view abstract

17. Emerging drugs for non-small-cell lung cancer.

Author
Felip E; Santarpia M; Rosell R;
Institution
Institut Catala d'Oncologia, Hospital Germans Trias I Pujol, Ctra. Canyet. s/n, 08916 Badalona, Barcelona, Spain.
Journal
Expert Opin Emerg Drugs. 2007 Sep;12(3):449-60.
Abstract URL
Click here to view abstract

18. Molecular predictors of chemotherapy response in non-small-cell lung cancer.

Author
Gray J; Simon G; Bepler G;
Institution
H Lee Moffitt Cancer Center & Research Institute, Division of Thoracic Oncology, Tampa, Florida 33612, USA. jhanelle.gray@moffitt.org
Journal
Expert Rev Anticancer Ther. 2007 Apr;7(4):545-9.
Abstract URL
Click here to view abstract

19. Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future.

Author
Potti A; Ganti AK;
Institution
Duke Institute for Genome Sciences and Policy, Division of Hematology, Duke University Medical Center, Box #3382, CIEMAS, Durham, NC 27710, USA. anil.potti@duke.edu
Journal
Expert Opin Biol Ther. 2006 Jul;6(7):709-16.
Abstract URL
Click here to view abstract

20. Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promises.

Author
Auberger J; Loeffler-Ragg J; Wurzer W; Hilbe W;
Institution
Department of Internal Medicine, Division of Hematology and Oncology, Medical University Innsbruck, Austria.
Journal
Curr Cancer Drug Targets. 2006 Jun;6(4):271-94.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9